Early Detection and Screening for Colorectal Neoplasia: Making Sense of the Guidelines Robert S. Bresalier INIVITED COMMENTARY 10 July 2010 Pages: 177 - 179
Optimal Adjuvant Therapy for Patients with Resected Rectal Cancers Francine AubinCharles D. Blanke INVITED COMMENTARY 05 August 2010 Pages: 180 - 182
Using The Colon Cancer Multigene Recurrence Score to Determine Risk: Prognostic Milestone or a Step in the Right Direction? Peter M. WilsonPierre BohanesHeinz-Josef Lenz ReviewPaper 13 July 2010 Pages: 183 - 192
Molecularly Targeted Therapy for Metastatic Colon Cancer: Proven Treatments and Promising New Agents Christina WuAline CharabatyJohn L. Marshall OriginalPaper 16 June 2010 Pages: 193 - 198
Management Strategies for Patients with KRAS Mutations Stephen LeongS. Gail EckhardtWells A. Messersmith ReviewPaper 04 August 2010 Pages: 199 - 205
The Biology of K-Ras and B-Raf Mutations in Colorectal Cancer Yixing JiangHeath MackleyJaffer A. Ajani ReviewPaper 14 August 2010 Pages: 206 - 211
Circulating Tumor Cells and Colorectal Cancer Joshua E. AllenWafik S. El-Deiry ReviewPaper 10 August 2010 Pages: 212 - 220
How Might Knowledge of the Molecular Biology of Rectal Cancer Aid Us in Deciding Treatment? Annelies DebucquoyKarin Haustermans ReviewPaper 21 July 2010 Pages: 221 - 227
Local Pelvic Relapses after Neoadjuvant High-dose Rate Endorectal Brachytherapy for Patients with Operable Rectal Cancer Té VuongTamim NiaziSlobodan Devic ReviewPaper 06 August 2010 Pages: 228 - 234